{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T08:02:50Z","timestamp":1779350570343,"version":"3.51.4"},"reference-count":175,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,2]]},"DOI":"10.1093\/ije\/dyg070","type":"journal-article","created":{"date-parts":[[2003,4,10]],"date-time":"2003-04-10T20:38:54Z","timestamp":1050007134000},"page":"1-22","source":"Crossref","is-referenced-by-count":5252,"title":["\u2018Mendelian randomization\u2019: can genetic epidemiology contribute to understanding environmental determinants of disease?*"],"prefix":"10.1093","volume":"32","author":[{"given":"George","family":"Davey Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shah","family":"Ebrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2003,2]]},"reference":[{"key":"key\n\t\t\t\t20170407090022_R1","doi-asserted-by":"crossref","unstructured":"Butler D. Epidemiology set to get fast-track treatment. Nature2001; 414:139.","DOI":"10.1038\/35102713"},{"key":"key\n\t\t\t\t20170407090022_R2","doi-asserted-by":"crossref","unstructured":"Khoury MJ, Dorman JS. The human genome epidemiology network (HuGE Net) Am J Epidemiol1998;148:1\u20133.","DOI":"10.1093\/aje\/148.1.1"},{"key":"key\n\t\t\t\t20170407090022_R3","doi-asserted-by":"crossref","unstructured":"Khoury MJ. Human Genome Epidemiology (HuGE): translating advances in human genetics into population-based data for medicine and public health. Genet Med1999;1:71\u201373.","DOI":"10.1097\/00125817-199903000-00002"},{"key":"key\n\t\t\t\t20170407090022_R4","doi-asserted-by":"crossref","unstructured":"Khoury MJ, Burke W, Thomson EJ (eds). Genetics and Public Health in the 21st Century. Oxford: Oxford University Press, 2000, pp. 10\u201311.","DOI":"10.1093\/acprof:oso\/9780195128307.001.0001"},{"key":"key\n\t\t\t\t20170407090022_R5","doi-asserted-by":"crossref","unstructured":"Porta M. The genome sequence is a jazz score. Int J Epidemiol2003; 32:29\u201331.","DOI":"10.1093\/ije\/dyg015"},{"key":"key\n\t\t\t\t20170407090022_R6","doi-asserted-by":"crossref","unstructured":"Vineis P, Schulte P, McMichael AJ. Misconceptions about the use of genetic tests in populations. Lancet;357:709\u201312.","DOI":"10.1016\/S0140-6736(00)04136-2"},{"key":"key\n\t\t\t\t20170407090022_R7","doi-asserted-by":"crossref","unstructured":"Katan MB. Apolipoprotein E isoforms, serum cholesterol, and cancer. Lancet1986;i:507\u201308.","DOI":"10.1016\/S0140-6736(86)92972-7"},{"key":"key\n\t\t\t\t20170407090022_R8","doi-asserted-by":"crossref","unstructured":"Ames BN. Cancer prevention and diet: Help from single nucleotide polymorphisms. PNAS1999;96:12216\u201318.","DOI":"10.1073\/pnas.96.22.12216"},{"key":"key\n\t\t\t\t20170407090022_R9","doi-asserted-by":"crossref","unstructured":"Rothman N, Wacholder S, Caporaso NE, Garcia-Closas M, Buetow K, Fraumeni JF. The use of common genetic polymorphisms to enhance the epidemiologic study of environmental carcinogens. Biochimica Biophysica Acta2001;1471:C1\u2013C10.","DOI":"10.1016\/S0304-419X(00)00021-4"},{"key":"key\n\t\t\t\t20170407090022_R10","doi-asserted-by":"crossref","unstructured":"Brennan P. Gene environment interaction and aetiology of cancer: what does it mean and how can we measure it? Carcinogenesis2002; 23:381\u201387.","DOI":"10.1093\/carcin\/23.3.381"},{"key":"key\n\t\t\t\t20170407090022_R11","unstructured":"Youngman LD, Keavney BD, Palmer A et al. Plasma fibrinogen and fibrinogen genotypes in 4685 cases of myocardial infarction and in 6002 controls: test of causality by \u2018Mendelian randomization\u2019. Circulation2000;102(Suppl.II):31\u201332."},{"key":"key\n\t\t\t\t20170407090022_R12","doi-asserted-by":"crossref","unstructured":"Clayton D, McKeigue PM. Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet2001; 358:1356\u201360.","DOI":"10.1016\/S0140-6736(01)06418-2"},{"key":"key\n\t\t\t\t20170407090022_R13","doi-asserted-by":"crossref","unstructured":"Fallon UB, Ben-Shlomo Y, Davey Smith G. Homocysteine and coronary heart disease. Heart Online 14 March 2001 (http:\/\/heart.bmjjournals.com\/cgi\/eletters\/85\/2\/153)","DOI":"10.1136\/heart.85.2.153"},{"key":"key\n\t\t\t\t20170407090022_R14","doi-asserted-by":"crossref","unstructured":"Keavney B. Genetic epidemiological studies of coronary heart disease. Int J Epidemiol2002;31:730\u201336.","DOI":"10.1093\/ije\/31.4.730"},{"key":"key\n\t\t\t\t20170407090022_R15","doi-asserted-by":"crossref","unstructured":"Davey Smith G, Ebrahim S. Data dredging, bias and confounding BMJ2002;325:1437\u201338.","DOI":"10.1136\/bmj.325.7378.1437"},{"key":"key\n\t\t\t\t20170407090022_R16","doi-asserted-by":"crossref","unstructured":"Feinstein AR. Scientific standards in epidemiologic studies of the menace of daily life. Science1988;242:1257\u201363.","DOI":"10.1126\/science.3057627"},{"key":"key\n\t\t\t\t20170407090022_R17","doi-asserted-by":"crossref","unstructured":"Taubes G. Epidemiology faces its limits. Science1995;269:164\u201369.","DOI":"10.1126\/science.7618077"},{"key":"key\n\t\t\t\t20170407090022_R18","doi-asserted-by":"crossref","unstructured":"Le Fanu J. The Rise and Fall of Modern Medicine. New York: Little Brown, 1999.","DOI":"10.1016\/S0140-6736(05)75559-8"},{"key":"key\n\t\t\t\t20170407090022_R19","unstructured":"Skrabanek P. False Premises, False Promises. Whithorn: Tarragon Press, 2000."},{"key":"key\n\t\t\t\t20170407090022_R20","doi-asserted-by":"crossref","unstructured":"Davey Smith G. Reflections on the limitations to epidemiology. J Clin Epidemiol2001;54:325\u201331.","DOI":"10.1016\/S0895-4356(00)00334-6"},{"key":"key\n\t\t\t\t20170407090022_R21","doi-asserted-by":"crossref","unstructured":"Peto R, Doll R, Buckley JD, Sporn MB. Can dietary beta-carotene materially reduce human cancer rates? Nature1981;290:201\u201308.","DOI":"10.1038\/290201a0"},{"key":"key\n\t\t\t\t20170407090022_R22","doi-asserted-by":"crossref","unstructured":"Willett WC. Vitamin A and lung cancer. Nutr Rev1990;48:201\u201311.","DOI":"10.1111\/j.1753-4887.1990.tb02936.x"},{"key":"key\n\t\t\t\t20170407090022_R23","doi-asserted-by":"crossref","unstructured":"Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med1994;330: 1029\u201335.","DOI":"10.1056\/NEJM199404143301501"},{"key":"key\n\t\t\t\t20170407090022_R24","doi-asserted-by":"crossref","unstructured":"Omenn GS, Goodman GE, Thornquist MD et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med1996;334:1150\u201355.","DOI":"10.1056\/NEJM199605023341802"},{"key":"key\n\t\t\t\t20170407090022_R25","doi-asserted-by":"crossref","unstructured":"Hennekens CH, Buring JE, Manson JE et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med1996;334:1145\u201349.","DOI":"10.1056\/NEJM199605023341801"},{"key":"key\n\t\t\t\t20170407090022_R26","doi-asserted-by":"crossref","unstructured":"Hooper L, Ness AR, Davey Smith G. Antioxidant strategy for cardiovascular diseases. Lancet2001;357:1705\u201306.","DOI":"10.1016\/S0140-6736(00)04876-5"},{"key":"key\n\t\t\t\t20170407090022_R27","doi-asserted-by":"crossref","unstructured":"Khaw K-T, Bingham S, Welch A et al. Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study. Lancet2001; 357:657\u201363.","DOI":"10.1016\/S0140-6736(00)04128-3"},{"key":"key\n\t\t\t\t20170407090022_R28","doi-asserted-by":"crossref","unstructured":"Heart Protection Study Collaborative Group. MRC\/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet2002;360:23\u201333.","DOI":"10.1016\/S0140-6736(02)09328-5"},{"key":"key\n\t\t\t\t20170407090022_R29","doi-asserted-by":"crossref","unstructured":"Davey Smith G, Phillips AN. Confounding in epidemiological studies: why \u2018independent\u2019 effects may not be all they seem. BMJ1992;305: 757\u201359.","DOI":"10.1136\/bmj.305.6856.757"},{"key":"key\n\t\t\t\t20170407090022_R30","doi-asserted-by":"crossref","unstructured":"Phillips A, Davey Smith G. How independent are \u2018independent\u2019 effects? Relative risk estimation when correlated exposures are measured imprecisely. J Clin Epidemiol1991;44:1223\u201331.","DOI":"10.1016\/0895-4356(91)90155-3"},{"key":"key\n\t\t\t\t20170407090022_R31","doi-asserted-by":"crossref","unstructured":"Phillips AN, Davey Smith G. The design of prospective epidemiological studies: more subjects or better measurements? J Clin Epidemiol1993; 46:1203\u201311.","DOI":"10.1016\/0895-4356(93)90120-P"},{"key":"key\n\t\t\t\t20170407090022_R32","doi-asserted-by":"crossref","unstructured":"Weiss NS. Can the \u2018specificity\u2019 of an association be rehabilitated as a basis for supporting a causal hypothesis? Epidemiology2002;13:6\u20138.","DOI":"10.1097\/00001648-200201000-00003"},{"key":"key\n\t\t\t\t20170407090022_R33","doi-asserted-by":"crossref","unstructured":"Petitti DB, Perlman JA, Sidney S. Postmenopausal estrogen use and heart disease. N Engl J Med1986;315:131\u201332.","DOI":"10.1056\/NEJM198607103150213"},{"key":"key\n\t\t\t\t20170407090022_R34","doi-asserted-by":"crossref","unstructured":"Phillips A. Balancing quantity and quality when designing epidemiological studies. Int J Epidemiol2003;32:58\u201359.","DOI":"10.1093\/ije\/dyg043"},{"key":"key\n\t\t\t\t20170407090022_R35","doi-asserted-by":"crossref","unstructured":"Phillips AN, Davey Smith G. Cigarette smoking as a potential cause of cervical cancer: has confounding been controlled? Int J Epidemiol1994;23:42\u201349.","DOI":"10.1093\/ije\/23.1.42"},{"key":"key\n\t\t\t\t20170407090022_R36","doi-asserted-by":"crossref","unstructured":"Greenland S. Basic methods for sensitivity analysis. Int J Epidemiol1996;25:1107\u201316.","DOI":"10.1093\/ije\/25.6.1107"},{"key":"key\n\t\t\t\t20170407090022_R37","doi-asserted-by":"crossref","unstructured":"Davey Smith G. The uses of \u2018The Uses of Epidemiology\u2019. Int J Epidemiol2001;30:1146\u201355.","DOI":"10.1093\/ije\/30.5.1146"},{"key":"key\n\t\t\t\t20170407090022_R38","unstructured":"Gray R, Wheatley K. How to avoid bias when comparing bone marrow transplantation with chemotherapy. Bone Marrow Transplant1991;7(Suppl.3):9\u201312."},{"key":"key\n\t\t\t\t20170407090022_R39","doi-asserted-by":"crossref","unstructured":"Ljungman P, De Witte T, Verdonck L et al. Bone marrow transplantation for acute myeloblastic leukaemia: an EBMT Leukaemia Working Party prospective analysis from HLA-typing. Br J Haematol1993;84:61\u201366.","DOI":"10.1111\/j.1365-2141.1993.tb03025.x"},{"key":"key\n\t\t\t\t20170407090022_R40","doi-asserted-by":"crossref","unstructured":"Keating S, de Witte T, Suciu S et al. The influence of HLA-matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMENA. Br J Haematol1998;102:1344\u201353.","DOI":"10.1111\/j.1365-2141.1998.896hm3674.x"},{"key":"key\n\t\t\t\t20170407090022_R41","doi-asserted-by":"crossref","unstructured":"Burnett AK, Wheatley K, Goldstone AH et al. The value of allogenic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial. Br J Haematol2002;118:385\u2013400.","DOI":"10.1046\/j.1365-2141.2002.03724.x"},{"key":"key\n\t\t\t\t20170407090022_R42","doi-asserted-by":"crossref","unstructured":"Bleakley M, Shaw PJ, Nielsen JM. Allogenic bone marrow transplantation for childhood relapsed acute lymphoblastic leukemia: comparison of outcome in patients with and without a matched family donor. Bone Marrow Transplant2002;31:1\u20137.","DOI":"10.1038\/sj.bmt.1703601"},{"key":"key\n\t\t\t\t20170407090022_R43","doi-asserted-by":"crossref","unstructured":"Harrison G, Richards S, Lawson S et al. on behalf of the MRC Childhood Leukaemia Working Party. Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial. Ann Oncol2000;11: 999\u20131006.","DOI":"10.1023\/A:1008381801403"},{"key":"key\n\t\t\t\t20170407090022_R44","unstructured":"Mendel G. Experiments in Plant Hybridization (1865). http:\/\/www.mendelweb.org\/archive\/Mendel.Experiments.txt (accessed 12 Dec 2002)."},{"key":"key\n\t\t\t\t20170407090022_R45","unstructured":"Elston R, Olson J, Palmer L (eds). Biostatistical Genetics and Genetic Epidemiology. Chichester: John Wiley & Sons, 2002, p. 285."},{"key":"key\n\t\t\t\t20170407090022_R46","unstructured":"Terwilliger JD, Goring HHH. Gene mapping in the 20th and 21st centuries: statistical methods, data analysis and experimental design. Hum Biol2000;72:63\u2013132."},{"key":"key\n\t\t\t\t20170407090022_R47","unstructured":"Talking Glossary: National Human Genome Research Institute. www.genome.gov\/glossary.cfm (accessed 12 Dec 2002)."},{"key":"key\n\t\t\t\t20170407090022_R48","unstructured":"Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet1993;52:506\u201316."},{"key":"key\n\t\t\t\t20170407090022_R49","doi-asserted-by":"crossref","unstructured":"Ahsan H, Hodge SE, Heiman GA, Begg MD, Susser ES. Relative risk for genetic associations: the case-parent triad as a variant of case-cohort design. Int J Epidemiol2002;31:669\u201378.","DOI":"10.1093\/ije\/31.3.669"},{"key":"key\n\t\t\t\t20170407090022_R50","doi-asserted-by":"crossref","unstructured":"Risch NJ. Searching for genetic determinants in the new millennium. Nature2000;405:847\u201356.","DOI":"10.1038\/35015718"},{"key":"key\n\t\t\t\t20170407090022_R51","doi-asserted-by":"crossref","unstructured":"Garcia-Palmiere MR, Sorlie PD, Costas R, Havlik RJ. An apparent inverse relationship between serum cholesterol and cancer mortality in Puerto Rico. Am J Epidemiol1981;114:29\u201340.","DOI":"10.1093\/oxfordjournals.aje.a113171"},{"key":"key\n\t\t\t\t20170407090022_R52","doi-asserted-by":"crossref","unstructured":"McMichael AJ, Jensen OM, Parkin DM, Zaridze DG. Dietary and endogenous cholesterol and human cancer. Epidemiol Rev1984;6:192\u2013216.","DOI":"10.1093\/oxfordjournals.epirev.a036271"},{"key":"key\n\t\t\t\t20170407090022_R53","doi-asserted-by":"crossref","unstructured":"Wessel N, Liestol K, Maehlen J, Brorson SH. The apolipoprotein E epsilon4 allele is no risk factor for prostate cancer in the Norwegian population. Br J Cancer2001;85:1418.","DOI":"10.1054\/bjoc.2001.2098"},{"key":"key\n\t\t\t\t20170407090022_R54","doi-asserted-by":"crossref","unstructured":"Niemi M, Kervinen K, Kiviniemi H et al. Apolipoprotein E phenotype, cholesterol and breast and prostate cancer. J Epidemiol Community Health2000;54:938\u201339.","DOI":"10.1136\/jech.54.12.938"},{"key":"key\n\t\t\t\t20170407090022_R55","doi-asserted-by":"crossref","unstructured":"Moysich KB, Freudenheim JL, Baker JA et al. Apolipoprotein E genetic polymorphism, serum lipoproteins, and breast cancer risk. Mol Carcinog2000;27:2\u20139.","DOI":"10.1002\/(SICI)1098-2744(200001)27:1<2::AID-MC2>3.0.CO;2-W"},{"key":"key\n\t\t\t\t20170407090022_R56","doi-asserted-by":"crossref","unstructured":"Ford ES, Smith SJ, Stroup DF, Steinberg KK, Mueller PW, Thacker SB. Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies. Int J Epidemiol2002;31:59\u201370.","DOI":"10.1093\/ije\/31.1.59"},{"key":"key\n\t\t\t\t20170407090022_R57","doi-asserted-by":"crossref","unstructured":"Homocysteine Lowering Trialists\u2019 Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomized controlled trials. BMJ1998;316:894\u201398.","DOI":"10.1136\/bmj.316.7135.894"},{"key":"key\n\t\t\t\t20170407090022_R58","doi-asserted-by":"crossref","unstructured":"Brattstro\u2033m L, Wilcken DEL. Homocysteine and cardiovascular disease: cause or effect? Am J Clin Nutr2000;72:315\u201323.","DOI":"10.1093\/ajcn\/72.2.315"},{"key":"key\n\t\t\t\t20170407090022_R59","doi-asserted-by":"crossref","unstructured":"Ueland PM, Refsum H, Beresford SAA, Vollset SE. The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr2000;72:324\u201332.","DOI":"10.1093\/ajcn\/72.2.324"},{"key":"key\n\t\t\t\t20170407090022_R60","doi-asserted-by":"crossref","unstructured":"Clarke R. An updated review of the published studies of homocysteine and cardiovascular disease. Int J Epidemiol2002;31:70\u201371.","DOI":"10.1093\/ije\/31.1.70"},{"key":"key\n\t\t\t\t20170407090022_R61","doi-asserted-by":"crossref","unstructured":"Schnyder G, Roffi M, Flammer Y, Pin R, Hess OM. Effect of homocysteine-lowering therapy with folic acid, vitamin B12 and vitamin B6 on clinical outcome after percutaneous coronary intervention. The Swiss Heart Study: a randomized controlled trial. JAMA2002;288:973\u201379.","DOI":"10.1001\/jama.288.8.973"},{"key":"key\n\t\t\t\t20170407090022_R62","doi-asserted-by":"crossref","unstructured":"Schnyder G, Roffi M, Flammer Y et al. Decreased rate of coronary restenosis with lowering of plasma homocysteine levels. N Engl J Med2001;345:1593\u2013600.","DOI":"10.1056\/NEJMoa011364"},{"key":"key\n\t\t\t\t20170407090022_R63","doi-asserted-by":"crossref","unstructured":"Vermeulen E. Stehouwer C, Twisk J et al. Effect of homocysteine lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomized placebo controlled trial. Lancet2000;355:517\u201322.","DOI":"10.1016\/S0140-6736(99)07391-2"},{"key":"key\n\t\t\t\t20170407090022_R64","doi-asserted-by":"crossref","unstructured":"Brattstr\u00f6m L, Wilcken D, \u00d6hrvik J, Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation1998;98:2520\u201326.","DOI":"10.1161\/01.CIR.98.23.2520"},{"key":"key\n\t\t\t\t20170407090022_R65","doi-asserted-by":"crossref","unstructured":"The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke. A meta-analysis. JAMA2002;288: 2015\u201322.","DOI":"10.1001\/jama.288.16.2015"},{"key":"key\n\t\t\t\t20170407090022_R66","doi-asserted-by":"crossref","unstructured":"Klerk M, Verhoef P, Clarke R et al. MTHFR 677C\u2192T polymorphism and risk of coronary heart disease. A meta-analysis. JAMA2002;288: 2023\u201331.","DOI":"10.1001\/jama.288.16.2023"},{"key":"key\n\t\t\t\t20170407090022_R67","doi-asserted-by":"crossref","unstructured":"Clarke R, Lewington S, Donald A et al. Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies. J Cardiovasc Risk2001;8:363\u201369.","DOI":"10.1177\/174182670100800605"},{"key":"key\n\t\t\t\t20170407090022_R68","doi-asserted-by":"crossref","unstructured":"Scholl TO, Johnson WG. Folic acid: influence on the outcome of pregnancy. Am J Clin Nutr2000;71(Suppl.):1295S\u2013303S.","DOI":"10.1093\/ajcn\/71.5.1295s"},{"key":"key\n\t\t\t\t20170407090022_R69","doi-asserted-by":"crossref","unstructured":"MRC Vitamin Study Research Group. Prevention of neural tube defects: Results of the Medical Research Council vitamin study. Lancet1991;338:131\u201337.","DOI":"10.1016\/0140-6736(91)90133-A"},{"key":"key\n\t\t\t\t20170407090022_R70","doi-asserted-by":"crossref","unstructured":"Czeizel AE, Dud\u00e1s I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. New Engl J Med1992;327:1832\u201335.","DOI":"10.1056\/NEJM199212243272602"},{"key":"key\n\t\t\t\t20170407090022_R71","doi-asserted-by":"crossref","unstructured":"Botto LD, Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE Review. Am J Epidemiol2000;151:862\u201377.","DOI":"10.1093\/oxfordjournals.aje.a010290"},{"key":"key\n\t\t\t\t20170407090022_R72","doi-asserted-by":"crossref","unstructured":"Steegers-Theunissen RPM, Boers GHJ, Trijbels FJM et al. Maternal hyperhomocysteinemia: a risk factor for neural tube defects? Metabolism1994;43:1475\u201380.","DOI":"10.1016\/0026-0495(94)90004-3"},{"key":"key\n\t\t\t\t20170407090022_R73","doi-asserted-by":"crossref","unstructured":"Rosenquist TH, Finnell RH. Genes, folate and homocysteine in embryonic development. Proc Nutr Soc2001;60:53\u201361.","DOI":"10.1017\/S0029665101000088"},{"key":"key\n\t\t\t\t20170407090022_R74","doi-asserted-by":"crossref","unstructured":"Mills JL, McPartlin MJ, Kirke PN et al. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet1995;345: 149\u201351.","DOI":"10.1016\/S0140-6736(95)90165-5"},{"key":"key\n\t\t\t\t20170407090022_R75","unstructured":"Andersson A, Hultberg B, Brattstrom L, Isaksson A. Decreased serum homocysteine in pregnancy. Eur J Clin Chem Clin Biochem1992;30: 377\u201379."},{"key":"key\n\t\t\t\t20170407090022_R76","doi-asserted-by":"crossref","unstructured":"Anonymous. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338:131\u201337.","DOI":"10.1016\/0140-6736(91)90133-A"},{"key":"key\n\t\t\t\t20170407090022_R77","doi-asserted-by":"crossref","unstructured":"Vollset SE, Refsum H, Irgens LM, Emblem BM, Tverdal A, Gjessing HK. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine Study. Am J Clin Nutr2000;71:962\u201368.","DOI":"10.1097\/00006254-200010000-00002"},{"key":"key\n\t\t\t\t20170407090022_R78","doi-asserted-by":"crossref","unstructured":"Marugame T, Tsuji E, Kiyohara C et al. Relation of plasma folate and methylenetetrahydrofolate reductase C677T polymorphism to colorectal cancer. Int J Epidemiol2003;32:64\u201366.","DOI":"10.1093\/ije\/dyg004"},{"key":"key\n\t\t\t\t20170407090022_R79","doi-asserted-by":"crossref","unstructured":"Fallon UB. Colon cancer, folate and genetic status. Int J Epidemiol2003;32:67\u201370.","DOI":"10.1093\/ije\/dyg115"},{"key":"key\n\t\t\t\t20170407090022_R80","doi-asserted-by":"crossref","unstructured":"Fenech M. The role of folic acid and Vitamin B12 in genomic stability of human cells. Mutat Res2001;475:57\u201367.","DOI":"10.1016\/S0027-5107(01)00079-3"},{"key":"key\n\t\t\t\t20170407090022_R81","doi-asserted-by":"crossref","unstructured":"Houlston RS, Tomlinson IPM. Polymorphisms and colorectal tumor risk. Gastroenterology2001;121:282\u2013301.","DOI":"10.1053\/gast.2001.26265"},{"key":"key\n\t\t\t\t20170407090022_R82","doi-asserted-by":"crossref","unstructured":"Le Marchand L, Donlon T, Hankin JH, Kolonel LN, Wilkens LR, Seifried A. B-vitamin intake, metabolic genes, and colorectal cancer risk (United States). Cancer Causes Control2002;13:239\u201348.","DOI":"10.1023\/A:1015057614870"},{"key":"key\n\t\t\t\t20170407090022_R83","doi-asserted-by":"crossref","unstructured":"Franco RF, Sim\u00f5es BP, Tone LG, Gabellini SM, Zago MA, Falc\u00e3o. The methylenetetrahydrofolate reductase C677T gene polymorphism decreases the risk of childhood acute lymphocytic leukaemia. Br J Haematol2001;115:616\u201318.","DOI":"10.1046\/j.1365-2141.2001.03140.x"},{"key":"key\n\t\t\t\t20170407090022_R84","doi-asserted-by":"crossref","unstructured":"Skibola CF, Smith MT, Kane E et al. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibil-ity to acute leukemia in adults. Proc Natl Acad Sci USA1999; 96:12810\u201315.","DOI":"10.1073\/pnas.96.22.12810"},{"key":"key\n\t\t\t\t20170407090022_R85","doi-asserted-by":"crossref","unstructured":"Zingg JM, Jones PA. Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. Carcinogenesis1997;18:869\u201382.","DOI":"10.1093\/carcin\/18.5.869"},{"key":"key\n\t\t\t\t20170407090022_R86","doi-asserted-by":"crossref","unstructured":"Marmot M. Commentary: Reflections on alcohol and coronary heart disease. Int J Epidemiol2001;30:729\u201334.","DOI":"10.1093\/ije\/30.4.729"},{"key":"key\n\t\t\t\t20170407090022_R87","doi-asserted-by":"crossref","unstructured":"Bovet P, Paccaud F. Commentary: Alcohol, coronary heart disease and public health: which evidence-based policy? Int J Epidemiol2001;30:734\u201337.","DOI":"10.1093\/ije\/30.4.734"},{"key":"key\n\t\t\t\t20170407090022_R88","doi-asserted-by":"crossref","unstructured":"Klatsky AL. Commentary: Could abstinence from alcohol be hazardous to your health? Int J Epidemiol2001;30:739\u201342.","DOI":"10.1093\/ije\/30.4.739"},{"key":"key\n\t\t\t\t20170407090022_R89","doi-asserted-by":"crossref","unstructured":"Shaper AG. Editorial: alcohol, the heart, and health. Am J Public Health1993;83:799\u2013801.","DOI":"10.2105\/AJPH.83.6.799"},{"key":"key\n\t\t\t\t20170407090022_R90","doi-asserted-by":"crossref","unstructured":"Hart CL, Davey Smith G, Hole DJ, Hawthorne VM. Alcohol consumption and mortality from all causes, coronary heart disease, and stroke: results from a prospective cohort study of Scottish men with 21 years of follow up. BMJ1999;318:1725\u201329.","DOI":"10.1136\/bmj.318.7200.1725"},{"key":"key\n\t\t\t\t20170407090022_R91","doi-asserted-by":"crossref","unstructured":"Rimm E. Commentary: Alcohol and coronary heart disease\u2014laying the foundation for future work. Int J Epidemiol2001;30:738\u201339.","DOI":"10.1093\/ije\/30.4.738"},{"key":"key\n\t\t\t\t20170407090022_R92","doi-asserted-by":"crossref","unstructured":"Eriksson CJP, Fukunaga T, Sarkola T et al. Functional relevance of human ADH polymorphism. Alcohol Clin Exp Res2001;25:157S\u201363S.","DOI":"10.1111\/j.1530-0277.2001.tb02391.x"},{"key":"key\n\t\t\t\t20170407090022_R93","doi-asserted-by":"crossref","unstructured":"Agarwal DP. Genetic polymorphisms of alcohol metabolizing enzymes. Pathol Biol2001;49:703\u201309.","DOI":"10.1016\/S0369-8114(01)00242-5"},{"key":"key\n\t\t\t\t20170407090022_R94","doi-asserted-by":"crossref","unstructured":"Whitfield JB, Nightingale BN, Bucholz KK, Madden PAF, Heath AC, Martin NG. ADH Genotypes and alcohol use and dependence in Europeans. Alcohol Clin Exp Res1998;22:1463\u201369.","DOI":"10.1111\/j.1530-0277.1998.tb03936.x"},{"key":"key\n\t\t\t\t20170407090022_R95","doi-asserted-by":"crossref","unstructured":"Hines LM, Stampfer MJ, Ma J et al. Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction. N Engl J Med2001;344: 549\u201355.","DOI":"10.1056\/NEJM200102223440802"},{"key":"key\n\t\t\t\t20170407090022_R96","unstructured":"Tadel M, Goldman D. Pharmacogenetics of alcohol response and alcoholism: the interplay of genes and environmental factors in thresholds for alcoholism. Drug Metabolism and Disposition2001;29: 489\u201394."},{"key":"key\n\t\t\t\t20170407090022_R97","doi-asserted-by":"crossref","unstructured":"Sun F, Tsuritani I, Yamada Y. Contribution of genetic polymorphisms in ethanol-metabolizing enzymes to problem drinking behavior in middle-aged Japanese men. Behav Genet2002;32:229\u201336.","DOI":"10.1023\/A:1019711812074"},{"key":"key\n\t\t\t\t20170407090022_R98","doi-asserted-by":"crossref","unstructured":"Nakamura Y, Amamoto K, Tamaki S et al. Genetic variation in aldehyde dehydrogenase 2 and the effect of alcohol consumption on cholesterol levels. Atherosclerosis2002;164:171\u201377.","DOI":"10.1016\/S0021-9150(02)00059-X"},{"key":"key\n\t\t\t\t20170407090022_R99","doi-asserted-by":"crossref","unstructured":"Haskell WL, Camargo C, Williams PT et al. The effect of cessation and resumption of moderate alcohol intake on serum high-density-lipoprotein subfractions. N Engl J Med1984;310:805\u201310.","DOI":"10.1056\/NEJM198403293101301"},{"key":"key\n\t\t\t\t20170407090022_R100","doi-asserted-by":"crossref","unstructured":"Burr ML, Fehily AM, Butland BK et al. Alcohol and high-density-lipoprotein cholesterol: a randomized controlled trial. Br J Nutr1986;56:81\u201386.","DOI":"10.1079\/BJN19860087"},{"key":"key\n\t\t\t\t20170407090022_R101","doi-asserted-by":"crossref","unstructured":"Cherry N, Mackness M, Durrington P et al. Paraoxonase (PON1) polymorphisms in farmers attributing ill health to sheep dip. Lancet2002;359:763\u201364.","DOI":"10.1016\/S0140-6736(02)07847-9"},{"key":"key\n\t\t\t\t20170407090022_R102","doi-asserted-by":"crossref","unstructured":"D\u2019Errico A, Taioli E, Chen X, Vineis P. Genetic metabolic polymorphisms and the risk of cancer: a review of the literature. Biomarkers1996;1:149\u201373.","DOI":"10.3109\/13547509609079352"},{"key":"key\n\t\t\t\t20170407090022_R103","unstructured":"Hein DW, Doll MA, Fretland AJ et al. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomark Prev2000;9:29\u201342."},{"key":"key\n\t\t\t\t20170407090022_R104","doi-asserted-by":"crossref","unstructured":"Vineis P, McMichael AJ. Interplay between heterocyclic amines in cooked meat and metabolic phenotype in the aetiology of colon cancer. Cancer Causes Control1996;7:479\u201386.","DOI":"10.1007\/BF00052675"},{"key":"key\n\t\t\t\t20170407090022_R105","doi-asserted-by":"crossref","unstructured":"Roberts-Thomson I, Ryan PR, Khoo K et al. Diet, acetylator phenotype and risk of colorectal neoplasia. Lancet1996;347: 1372\u201374.","DOI":"10.1016\/S0140-6736(96)91012-0"},{"key":"key\n\t\t\t\t20170407090022_R106","doi-asserted-by":"crossref","unstructured":"Colhoun H, KcKeigue PM, Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 2003, in press.","DOI":"10.1016\/S0140-6736(03)12715-8"},{"key":"key\n\t\t\t\t20170407090022_R107","doi-asserted-by":"crossref","unstructured":"Tybjaerg-Hansen A, Agerholm-Larsen B, Humphries SE, Abildgaard S, Schnohr P, Nordestgaard BG. A common mutation (G_455\u2192A) in the \u03b2-Fibrinogen promoter is an independent predictor of plama fibrinogen, but not of ischaemic heart disease. J Clin Invest1999:3034\u201339.","DOI":"10.1172\/JCI119499"},{"key":"key\n\t\t\t\t20170407090022_R108","doi-asserted-by":"crossref","unstructured":"Van der Bom JG, De Maat MPM, Bots ML et al. Elevated plasma fibrinogen. Cause or consequence of cardiovascular disease? Arterioscler Thromb Vasc Biol1998;18:621\u201325.","DOI":"10.1161\/01.ATV.18.4.621"},{"key":"key\n\t\t\t\t20170407090022_R109","doi-asserted-by":"crossref","unstructured":"Doggen CJM, Bertina RM, Manger Cats V, Rosendaal FR. Fibrinogen polymorphisms are not associated with the risk of myocardial infarction. Br J Haematol2000;110:935\u201338.","DOI":"10.1046\/j.1365-2141.2000.02266.x"},{"key":"key\n\t\t\t\t20170407090022_R110","doi-asserted-by":"crossref","unstructured":"Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, c-reactive protein, albumin, or leukocyte count with coronary heart disease. JAMA1998;279:1477\u201382.","DOI":"10.1001\/jama.279.18.1477"},{"key":"key\n\t\t\t\t20170407090022_R111","doi-asserted-by":"crossref","unstructured":"Brunner E, Davey Smith G, Marmot M, Canner R, Beksinska M, O\u2019Brien J. Childhood social circumstances and psychosocial and behavioural factors as determinants of plasma fibrinogen. Lancet1996;347:1008\u201313.","DOI":"10.1016\/S0140-6736(96)90147-6"},{"key":"key\n\t\t\t\t20170407090022_R112","doi-asserted-by":"crossref","unstructured":"Antithrombotic Trialists\u2019 Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ2002; 324:71\u201386.","DOI":"10.1136\/bmj.324.7329.71"},{"key":"key\n\t\t\t\t20170407090022_R113","doi-asserted-by":"crossref","unstructured":"Anand SS, Yusuf S. Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis. JAMA1999;282:2058\u201367.","DOI":"10.1001\/jama.282.21.2058"},{"key":"key\n\t\t\t\t20170407090022_R114","doi-asserted-by":"crossref","unstructured":"The Coronary Drug Project Research Group: Clofibrate and niacin in coronary heart disease. The coronary drug project research group. JAMA1975;231:360\u201380.","DOI":"10.1001\/jama.1975.03240160024021"},{"key":"key\n\t\t\t\t20170407090022_R115","doi-asserted-by":"crossref","unstructured":"Meade T, Zuhrie R, Cook C, Cooper J. Bezafibrate in men with lower extremity arterial disease: randomised controlled trial. BMJ2002; 325:1139.","DOI":"10.1136\/bmj.325.7373.1139"},{"key":"key\n\t\t\t\t20170407090022_R116","doi-asserted-by":"crossref","unstructured":"Ebrahim S, Davey Smith G, McCabe C et al. Cholesterol and coronary heart disease: screening and treatment. Qual Health Care1998;7:232\u201339.","DOI":"10.1136\/qshc.7.4.232"},{"key":"key\n\t\t\t\t20170407090022_R117","doi-asserted-by":"crossref","unstructured":"Scientific Steering Committee on behalf of the Simon Broome Register Group. Risk of fatal coronary heart disease in familial hypercholesterolaemia. BMJ1991;303:893\u201396.","DOI":"10.1136\/bmj.303.6807.893"},{"key":"key\n\t\t\t\t20170407090022_R118","unstructured":"Hallman DM, Boerwinkle E, Saha N et al. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet1991;49:338\u201349."},{"key":"key\n\t\t\t\t20170407090022_R119","doi-asserted-by":"crossref","unstructured":"Frikke-Schmidt R, Nordestgaard BG, Agerholm-Larsen B, Schnohr P, Tybjaerg-Hansen A. Context-dependent and invariant associations between lipids, lipoproteins, and apolipoproteins and apolipoprotein E genotype. J Lipid Res2000;41:1812\u201322.","DOI":"10.1016\/S0022-2275(20)31975-1"},{"key":"key\n\t\t\t\t20170407090022_R120","doi-asserted-by":"crossref","unstructured":"Keavney BD, Youngman LD, Palmer A et al. Large-scale test of hypothesized associations between polymorphisms of lipid-related genes and myocardial infarction in about 5000 cases and 6000 controls. Circulation2000;102(Suppl.II):852.","DOI":"10.1016\/S0140-6736(99)07192-5"},{"key":"key\n\t\t\t\t20170407090022_R121","doi-asserted-by":"crossref","unstructured":"Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis1988:8:1\u201321.","DOI":"10.1161\/01.ATV.8.1.1"},{"key":"key\n\t\t\t\t20170407090022_R122","doi-asserted-by":"crossref","unstructured":"Heart Protection Study Collaborative Group. MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet2002;360:7\u201322.","DOI":"10.1016\/S0140-6736(02)09327-3"},{"key":"key\n\t\t\t\t20170407090022_R123","doi-asserted-by":"crossref","unstructured":"Smith J. Apolipoproteins and aging: emerging mechanisms. Ageing Research Reviews2002;1:345\u201365.","DOI":"10.1016\/S1568-1637(02)00005-3"},{"key":"key\n\t\t\t\t20170407090022_R124","doi-asserted-by":"crossref","unstructured":"Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE Review. Am J Epidemiol2002;155:487\u201395.","DOI":"10.1093\/aje\/155.6.487"},{"key":"key\n\t\t\t\t20170407090022_R125","doi-asserted-by":"crossref","unstructured":"Wilson PWF, Schaefer EJ, Larson MG, Ordovas JM. Apolipoprotein E alleles and risk of coronary disease. Arterioscl Thromb Vasc Biol1996;16:1250\u201355.","DOI":"10.1161\/01.ATV.16.10.1250"},{"key":"key\n\t\t\t\t20170407090022_R126","unstructured":"http:\/\/www.ncbi.nlm.nih.gov\/Omim (accessed 12 Dec 2002)."},{"key":"key\n\t\t\t\t20170407090022_R127","unstructured":"http:\/\/archive.uwcm.ac.uk\/uwcm\/mg\/hgmd0.html (accessed 12 Dec 2002)."},{"key":"key\n\t\t\t\t20170407090022_R128","unstructured":"http:\/\/hgvbase.cgb.ki.se\/about.htm (accessed 12 Dec 2002)."},{"key":"key\n\t\t\t\t20170407090022_R129","doi-asserted-by":"crossref","unstructured":"Langlois MR, Delanghe JR, De Buyzere ML, Bernard DR, Ouyang J. Effect of haptoglobin on the metabolism of vitamin C. Am J Clin Nutr1997;66:606\u201310.","DOI":"10.1093\/ajcn\/66.3.606"},{"key":"key\n\t\t\t\t20170407090022_R130","doi-asserted-by":"crossref","unstructured":"Delanghe J, Langlois M, Duprez D, De Buyzere M, Clement D. Haptoglobin polymorphism and peripheral arterial occlusive disease. Atherosclerosis1999;145:287\u201392.","DOI":"10.1016\/S0021-9150(99)00079-9"},{"key":"key\n\t\t\t\t20170407090022_R131","doi-asserted-by":"crossref","unstructured":"Delanghe J, Cambier B, Langlois M et al. Haptoglobin polymorphism, a genetic risk factor in coronary artery bypass surgery. Atherosclerosis1997;132:215\u201319.","DOI":"10.1016\/S0021-9150(97)00089-0"},{"key":"key\n\t\t\t\t20170407090022_R132","doi-asserted-by":"crossref","unstructured":"De Bacquer D, De Backer G, Langlois M, Delanghe J, Kesteloot H, Kornitzer M. Haptoglobin polymorphism as a risk factor for coronary heart disease mortality. Atherosclerosis2001;157:161\u201366.","DOI":"10.1016\/S0021-9150(00)00690-0"},{"key":"key\n\t\t\t\t20170407090022_R133","doi-asserted-by":"crossref","unstructured":"Cardon LR, Bell JI. Association study designs for complex diseases. Nature Rev: Genetics2001;2:91\u201399.","DOI":"10.1038\/35052543"},{"key":"key\n\t\t\t\t20170407090022_R134","doi-asserted-by":"crossref","unstructured":"Wacholder S, Rothman N, Caporaso N. Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. J Natl Cancer Inst2000;92:1151\u201358.","DOI":"10.1093\/jnci\/92.14.1151"},{"key":"key\n\t\t\t\t20170407090022_R135","unstructured":"Wacholder S, Rothman N, Caporaso N. Counterpoint: Bias from population stratification is not a major threat to the validity of conclusions from epidemiological studies of common polymorphisms and cancer. Cancer Epidemiol Biomark Prev2002;11:513\u2013520."},{"key":"key\n\t\t\t\t20170407090022_R136","doi-asserted-by":"crossref","unstructured":"Cardon LR, Palmer LJ. Wagging the dog? Population stratification and spurious allelic association. Lancet2003;361:598\u2013604.","DOI":"10.1016\/S0140-6736(03)12520-2"},{"key":"key\n\t\t\t\t20170407090022_R137","doi-asserted-by":"crossref","unstructured":"Sijbrands EJG, Westengorp RGJ, Defesche JC, De Meier PHEM, Smelt AHM, Kastelein JJP. Mortality over two centuries in large pedigrees with familial hypercholesterolaemia: family tree mortality study. BMJ2001;322:1019\u201323.","DOI":"10.1136\/bmj.322.7293.1019"},{"key":"key\n\t\t\t\t20170407090022_R138","doi-asserted-by":"crossref","unstructured":"Pimstone SN, Sun X-M, Du Souich C, Frohlich JJ, Hayden MR, Soutar AK. Phenotypic variation in heterozygous familial hypercholesterolemia. Arterioscler Thromb Vasc Biol1998;18:309\u201315.","DOI":"10.1161\/01.ATV.18.2.309"},{"key":"key\n\t\t\t\t20170407090022_R139","doi-asserted-by":"crossref","unstructured":"Tabor HK, Risch NJ, Myers RM. Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genetics2002;3:391\u201397.","DOI":"10.1038\/nrg796"},{"key":"key\n\t\t\t\t20170407090022_R140","doi-asserted-by":"crossref","unstructured":"Stephens JC, Schneider JA, Tanguay DA et al. Haplotype variation and linkage disequilibrium in 313 human genes. Science2001; 293:489\u201393.","DOI":"10.1126\/science.1059431"},{"key":"key\n\t\t\t\t20170407090022_R141","doi-asserted-by":"crossref","unstructured":"Osier MV, Pakstis AJ, Soodyall H et al. A global perspective on genetic variation at the ADH genes reveals unusual patterns of linkage disequilibrium and diversity. Am J Hum Genet2002;71:84\u201399.","DOI":"10.1086\/341290"},{"key":"key\n\t\t\t\t20170407090022_R142","doi-asserted-by":"crossref","unstructured":"Glebart WM. Databases in genomic research. Science1998;282: 659\u201361.","DOI":"10.1126\/science.282.5389.659"},{"key":"key\n\t\t\t\t20170407090022_R143","doi-asserted-by":"crossref","unstructured":"Waddington CH. Canalization of development and the inheritance of acquired characteristics. Nature1942;150:563\u201365.","DOI":"10.1038\/150563a0"},{"key":"key\n\t\t\t\t20170407090022_R144","doi-asserted-by":"crossref","unstructured":"Wilkins AS. Canalization: a molecular genetic perspective. BioEssays1997;19:257\u201362.","DOI":"10.1002\/bies.950190312"},{"key":"key\n\t\t\t\t20170407090022_R145","doi-asserted-by":"crossref","unstructured":"Rutherford SL. From genotype to phenotype: buffering mechanisms and the storage of genetic information. BioEssays2000;22: 1095\u2013105.","DOI":"10.1002\/1521-1878(200012)22:12<1095::AID-BIES7>3.0.CO;2-A"},{"key":"key\n\t\t\t\t20170407090022_R146","doi-asserted-by":"crossref","unstructured":"Gibson G, Wagner G. Canalization in evoluationary genetics: a stabilizing theory? BioEssays2000;22:372\u201380.","DOI":"10.1002\/(SICI)1521-1878(200004)22:4<372::AID-BIES7>3.0.CO;2-J"},{"key":"key\n\t\t\t\t20170407090022_R147","doi-asserted-by":"crossref","unstructured":"Hartman JL, Garvik B, Hartwell L. Principles for the buffering of genetic variation. Science2001;291:1001\u201304.","DOI":"10.1126\/science.291.5506.1001"},{"key":"key\n\t\t\t\t20170407090022_R148","doi-asserted-by":"crossref","unstructured":"Debat V, David P. Mapping phenotypes: canalization, plasticity and developmental stability. Trends in Ecology and Evolution2001;16: 555\u201361.","DOI":"10.1016\/S0169-5347(01)02266-2"},{"key":"key\n\t\t\t\t20170407090022_R149","doi-asserted-by":"crossref","unstructured":"Kitami T, Nadeau JH. Biochemical networking contributes more to genetic buffering in human and mouse metabolic pathways than does gene duplication. Nature Genet2002;32:191\u201394.","DOI":"10.1038\/ng945"},{"key":"key\n\t\t\t\t20170407090022_R150","doi-asserted-by":"crossref","unstructured":"Gu Z, Steinmetz LM, Gu X, Scharfe C, Davis RW, Li W-H. Role of duplicate genes in genetic robustness against null mutations. Nature2003;421:63\u201366.","DOI":"10.1038\/nature01198"},{"key":"key\n\t\t\t\t20170407090022_R151","unstructured":"Morange M. The Misunderstood Gene. Cambridge: Harvard University Press, 2001."},{"key":"key\n\t\t\t\t20170407090022_R152","doi-asserted-by":"crossref","unstructured":"Bolon B, Galbreath E. Use of genetically engineered mice in drug discovery and development: wielding Occam\u2019s razor to prune the product portfolio. Int J\u2008Toxicol2002;21:55\u201364.","DOI":"10.1080\/10915810252826019"},{"key":"key\n\t\t\t\t20170407090022_R153","doi-asserted-by":"crossref","unstructured":"Gerlai R. Gene targeting: technical confounds and potential solutions in behavioural and brain research. Behavioural Brain Research2001;125:13\u201321.","DOI":"10.1016\/S0166-4328(01)00282-0"},{"key":"key\n\t\t\t\t20170407090022_R154","doi-asserted-by":"crossref","unstructured":"Williams RS, Wagner PD. Transgenic animals in integrative biology: approaches and interpretations of outcome. J Appl Physiol2000; 88:1119\u201326.","DOI":"10.1152\/jappl.2000.88.3.1119"},{"key":"key\n\t\t\t\t20170407090022_R155","doi-asserted-by":"crossref","unstructured":"Garry DJ, Ordway GA, Lorenz JN, Radford ER, Chin RW, Grange R et al. Mice without myoglobin. Nature1998;395:905\u201308.","DOI":"10.1038\/27681"},{"key":"key\n\t\t\t\t20170407090022_R156","doi-asserted-by":"crossref","unstructured":"Gabriel SE, Jaakimainen L, Bombardier C. Risk for serious gastro-intestinal complications related to use of nonsteroidal anti-inflammatory drugs: a meta-analysis. Ann Intern Med1991;115: 787\u201396.","DOI":"10.7326\/0003-4819-115-10-787"},{"key":"key\n\t\t\t\t20170407090022_R157","doi-asserted-by":"crossref","unstructured":"Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis. Proc. Natl. Acad. Sci, USA 1999;96:7563\u201368.","DOI":"10.1073\/pnas.96.13.7563"},{"key":"key\n\t\t\t\t20170407090022_R158","doi-asserted-by":"crossref","unstructured":"Langenbach R, Morham SG, Tiano HF et al. Prostaglandin synthase gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell1995;83: 483\u201392.","DOI":"10.1016\/0092-8674(95)90126-4"},{"key":"key\n\t\t\t\t20170407090022_R159","doi-asserted-by":"crossref","unstructured":"De Witt D, Smith WL. Yes, but do they still get headaches? Cell1995;83:345\u201348.","DOI":"10.1016\/0092-8674(95)90109-4"},{"key":"key\n\t\t\t\t20170407090022_R160","doi-asserted-by":"crossref","unstructured":"Peskar BM. Role of cyclooxygenase isoforms in gastric mucosal defense. Journal of Physiology\u2014Paris2001;95:3\u20139.","DOI":"10.1016\/S0928-4257(01)00003-1"},{"key":"key\n\t\t\t\t20170407090022_R161","doi-asserted-by":"crossref","unstructured":"Gretzer B, Maricic N, Respondek M, Schuligoi R, Peskar BM. Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge. British Journal of Pharmacology2001;132:1565\u201373.","DOI":"10.1038\/sj.bjp.0703955"},{"key":"key\n\t\t\t\t20170407090022_R162","doi-asserted-by":"crossref","unstructured":"Wright AF, Carothers AD, Campbell H. Gene-environment interactions\u2014the BioBank UK study. Pharmacogenomics Journal2002;2:75\u201382.","DOI":"10.1038\/sj.tpj.6500085"},{"key":"key\n\t\t\t\t20170407090022_R163","doi-asserted-by":"crossref","unstructured":"Weiss K, Terwilliger J. How many diseases does it take to map a gene with SNPs? Nat Genet2000;26:151\u201357.","DOI":"10.1038\/79866"},{"key":"key\n\t\t\t\t20170407090022_R164","doi-asserted-by":"crossref","unstructured":"Erichsen HC, Eck P, Levine M, Chanock S. Characterization of the genomic structure of the human vitamin C transporter SVCT1 (SLC23A2). J\u2008Nutr2001;131:2623\u201327.","DOI":"10.1093\/jn\/131.10.2623"},{"key":"key\n\t\t\t\t20170407090022_R165","doi-asserted-by":"crossref","unstructured":"Perera FP. Environment and cancer: who are susceptible? Science1997;278:1068\u201373.","DOI":"10.1126\/science.278.5340.1068"},{"key":"key\n\t\t\t\t20170407090022_R166","doi-asserted-by":"crossref","unstructured":"Mucci LA, Wedren S, Tamimi RM, Trichopoulos D, Adami HO. The role of gene-environment interaction in the aetiology of human cancer: examples from cancers of the large bowel, lung and breast. Journal of Internal Medicine2001;249:477\u201393.","DOI":"10.1046\/j.1365-2796.2001.00839.x"},{"key":"key\n\t\t\t\t20170407090022_R167","unstructured":"Chen J, Stampfer MJ, Hough HL et al. A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer. Cancer Res1998;58:3307\u201311."},{"key":"key\n\t\t\t\t20170407090022_R168","unstructured":"Kampman E, Slattery ML, Bigler J et al. Meat consumption, genetic susceptibility, and colon cancer risk: a United States multi-center case-control study. Cancer Epidemiol Biomarkers Prev1999;8:15\u201324."},{"key":"key\n\t\t\t\t20170407090022_R169","doi-asserted-by":"crossref","unstructured":"Welfare MR, Cooper J, Bassendine MF, Daly AK. Relationship between acetylator status, smoking, and diet and colorectal cancer risk in the north-east of England. Carcinogenesis1997;18:1351\u201354.","DOI":"10.1093\/carcin\/18.7.1351"},{"key":"key\n\t\t\t\t20170407090022_R170","doi-asserted-by":"crossref","unstructured":"Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastin survival Study (4S). Lancet1994;344:1383\u201389.","DOI":"10.1016\/S0140-6736(94)90566-5"},{"key":"key\n\t\t\t\t20170407090022_R171","doi-asserted-by":"crossref","unstructured":"Heart Protection Study Collaborative Group. MRC\/BHF heart protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals. Lancet2002;360:7\u201322.","DOI":"10.1016\/S0140-6736(02)09327-3"},{"key":"key\n\t\t\t\t20170407090022_R172","doi-asserted-by":"crossref","unstructured":"Shepherd J, Cobbe SM, Ford I et al. for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med1995;333:1301\u201307.","DOI":"10.1056\/NEJM199511163332001"},{"key":"key\n\t\t\t\t20170407090022_R173","doi-asserted-by":"crossref","unstructured":"Bateson W. Mendel\u2019s Principles of Heredity. Cambridge: Cambridge University Press, 1909.","DOI":"10.5962\/bhl.title.44575"},{"key":"key\n\t\t\t\t20170407090022_R174","doi-asserted-by":"crossref","unstructured":"Fisher RA. Has Mendel\u2019s work been rediscovered? Annals of Science1936;1:115\u201337.","DOI":"10.1080\/00033793600200111"},{"key":"key\n\t\t\t\t20170407090022_R175","doi-asserted-by":"crossref","unstructured":"Sapp J. The nine lives of Gregor Mendel. In: Le Grand HE (ed.) Environmental Enquiries. London: Kluwer Academic Publishers, 1990, pp. 137\u201366.","DOI":"10.1007\/978-94-009-2057-6_5"}],"container-title":["International Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ije\/article-pdf\/32\/1\/1\/11213726\/320001_dyg070.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,6]],"date-time":"2021-06-06T01:59:35Z","timestamp":1622944775000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ije\/article-lookup\/doi\/10.1093\/ije\/dyg070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2]]},"references-count":175,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2003,2]]},"published-print":{"date-parts":[[2003,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ije\/dyg070","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717968276.793467988","asserted-by":"object"}]},"ISSN":["1464-3685","0300-5771"],"issn-type":[{"value":"1464-3685","type":"electronic"},{"value":"0300-5771","type":"print"}],"subject":[],"published":{"date-parts":[[2003,2]]}}}